Skip to main content
BI

Bio Usawa

San Francisco, United States
Last funding
$500K
Venture - Series UnknownDec 2025

Bio Usawa is a biotechnology company that develops monoclonal antibodies for cancer, ophthalmic, and infectious diseases.

About Bio Usawa

How much funding has Bio Usawa raised?

Bio Usawa has raised $500K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.

Where is Bio Usawa headquartered?

Bio Usawa is headquartered in San Francisco, United States.

What does Bio Usawa do?

Bio Usawa is a biotechnology company that develops monoclonal antibodies for cancer, ophthalmic, and infectious diseases.

What stage is Bio Usawa at?

Bio Usawa is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Bio Usawa — Funding & Investors." VCBacked, December 17, 2025, https://www.vcbacked.co/company/bio-usawa. Accessed November 15, 2026.
APA
VCBacked. (2025). Bio Usawa — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/bio-usawa
Wikipedia (cite web)
{{cite web |title=Bio Usawa — Funding & Investors |url=https://www.vcbacked.co/company/bio-usawa |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Bio Usawa? Request a listing update

Founder contacts
m***@biousawa.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →